Cravath represented the initial purchasers and dealer manager in the offering. The Chemours Company, a leading global provider of performance chemicals, executed its $800 million 144A/Reg….
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
